Zaman V, Matzelle D, Banik N, Haque A
Cells. 2025; 14(2).
PMID: 39851552
PMC: 11764466.
DOI: 10.3390/cells14020124.
Zhu Y, Shrestha A
Clin Oral Investig. 2025; 29(1):67.
PMID: 39825203
DOI: 10.1007/s00784-025-06161-3.
Mustata M, Ionescu M, Radu L, Neagoe C, Ahritculesei R, Cimpeanu R
Diagnostics (Basel). 2025; 14(24.
PMID: 39767248
PMC: 11675552.
DOI: 10.3390/diagnostics14242887.
Valencia-Ortega J, Castillo-Santos A, Moleres-Orduna M, Solis-Paredes J, Saucedo R, Estrada-Gutierrez G
Int J Mol Sci. 2024; 25(21).
PMID: 39519203
PMC: 11547085.
DOI: 10.3390/ijms252111655.
do Carmo J, Hall J, Furukawa L, Woronik V, Dai X, Ladnier E
Am J Physiol Renal Physiol. 2024; 327(6):F957-F966.
PMID: 39361725
PMC: 11687842.
DOI: 10.1152/ajprenal.00158.2024.
Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis.
Han L, Xu S, Zhou D, Chen R, Ding Y, Zhang M
Front Endocrinol (Lausanne). 2024; 15:1401648.
PMID: 38899007
PMC: 11185996.
DOI: 10.3389/fendo.2024.1401648.
The molecular mechanism of macrophage-adipocyte crosstalk in maintaining energy homeostasis.
Zhang Y, Zhang B, Sun X
Front Immunol. 2024; 15:1378202.
PMID: 38650945
PMC: 11033412.
DOI: 10.3389/fimmu.2024.1378202.
Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies.
Croce L, Beneventi F, Ripepi F, De Maggio I, Malovini A, Bellingeri C
Eur Thyroid J. 2024; 13(2).
PMID: 38417259
PMC: 11046355.
DOI: 10.1530/ETJ-23-0213.
Disparities in Breast Cancer Care-How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity.
Wilkerson A, Gentle C, Ortega C, Al-Hilli Z
Healthcare (Basel). 2024; 12(4).
PMID: 38391837
PMC: 10887556.
DOI: 10.3390/healthcare12040462.
Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?.
Mendes A, Freitas A, Vicente R, Vitorino M, Vaz Batista M, Silva M
Int J Mol Sci. 2023; 24(23).
PMID: 38068912
PMC: 10706733.
DOI: 10.3390/ijms242316589.
Leptin favors imbalance of antigen-specific CD4 T-cells associated with severity of cat allergy.
Vollmer C, Dias A, Sales M, Sacramento P, Silva J, Oyamada H
Front Immunol. 2023; 14:1290740.
PMID: 37954580
PMC: 10639137.
DOI: 10.3389/fimmu.2023.1290740.
Diabetes Mellitus, Energy Metabolism, and COVID-19.
Conte C, Cipponeri E, Roden M
Endocr Rev. 2023; 45(2):281-308.
PMID: 37934800
PMC: 10911957.
DOI: 10.1210/endrev/bnad032.
Excessive Pregestational Weight and Maternal Obstetric Complications: The Role of Adipokines.
Valencia-Ortega J, Solis-Paredes J, Saucedo R, Estrada-Gutierrez G, Camacho-Arroyo I
Int J Mol Sci. 2023; 24(19).
PMID: 37834125
PMC: 10572963.
DOI: 10.3390/ijms241914678.
Roles of four targets in the pathogenesis of graves' orbitopathy.
Ren Z, Zhang H, Yu H, Zhu X, Lin J
Heliyon. 2023; 9(9):e19250.
PMID: 37810014
PMC: 10558314.
DOI: 10.1016/j.heliyon.2023.e19250.
Highlighting the idea of exerkines in the management of cancer patients with cachexia: novel insights and a critical review.
Ahmadi Hekmatikar A, Nelson A, Petersen A
BMC Cancer. 2023; 23(1):889.
PMID: 37730552
PMC: 10512651.
DOI: 10.1186/s12885-023-11391-3.
Role of Leptin and Adiponectin in Carcinogenesis.
Bocian-Jastrzebska A, Malczewska-Herman A, Kos-Kudla B
Cancers (Basel). 2023; 15(17).
PMID: 37686525
PMC: 10486522.
DOI: 10.3390/cancers15174250.
Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data.
Vick L, Canter R, Monjazeb A, Murphy W
Semin Cancer Biol. 2023; 95:88-102.
PMID: 37499846
PMC: 10836337.
DOI: 10.1016/j.semcancer.2023.07.004.
Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes.
Liu M, Li C, Qu J, Sun S, Zhao Z, Wang W
Cancer Sci. 2023; 114(10):3834-3847.
PMID: 37489486
PMC: 10551602.
DOI: 10.1111/cas.15916.
Predicting in-hospital mortality risk for perforated peptic ulcer surgery: the PPUMS scoring system and the benefit of laparoscopic surgery: a population-based study.
Huang Y, Wu K, Su Y, Chen C, Chen J
Surg Endosc. 2023; 37(9):6834-6843.
PMID: 37308764
DOI: 10.1007/s00464-023-10180-0.
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
Incorvaia L, Rinaldi G, Badalamenti G, Cucinella A, Brando C, Madonia G
Ther Adv Med Oncol. 2023; 15:17588359231151845.
PMID: 36818688
PMC: 9936535.
DOI: 10.1177/17588359231151845.